Shares in US biotech Y-mAbs Therapeutics have lost almost a third of their value after FDA advisors unanimously rejected its brain cancer therapy 131I-omburtamab in 16 to 0 vote. The Oncologic Drugs ...

Cold feet are leading to more home sales falling through than surveys or mortgage issues, according to new research from LRG, but the property services group says it is “fixable” if Government reforms ...

Correspondence to Professor Julia Mayerle, Department of Medicine II, LMU University Hospital, Munich 81377, Germany; julia.mayerle{at}med.uni-muenchen.de Objective In up to 20% of patients, the ...

From defense to oil to tech, new companies are supporting the Kennedy Center since Trump’s takeover while others are revising their disclosure practices to explicitly honor the president.

September 7, 2021, Book: "How we became so burdened by red tape and unnecessary paperwork, and why we must do better. We've all had to fight our way through administrative sludge—filling out ...